Loading...
First Tracks Biotherapeutics (TRAX, $42.03) was one of top quarterly gainers, jumping +10 to $42.03 per share. A.I.dvisor analyzed 588 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down.